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ABSTRACT 10 
  11 
Pat1 is a key cytoplasmic mRNA degradation factor, the loss of which severely increases mRNA half-lives. Several 12 
recent studies have shown that Pat1 can enter the nucleus and can shuttle between the nucleus and the cytoplasm 13 
As a result, many nuclear roles have been proposed for Pat1. In this study, we analyzed four previously suggested 14 
nuclear roles of Pat1 and show that Pat1 is not required for efficient pre-mRNA splicing or pre-mRNA decay in 15 
yeast. However, lack of Pat1 results in accumulation of pre-rRNA processing intermediates. Intriguingly, we 16 
identified a novel genetic relationship between Pat1 and the rRNA decay machinery, specifically the exosome and 17 
the TRAMP complex. While the pre-rRNA processing intermediates that accumulate in the pat1 deletion mutant 18 
are, at least to some extent, recognized as aberrant by the rRNA degradation machinery, it is unlikely that these 19 
accumulations are the cause of their synthetic sick relationship. Here, we show that the dysregulation of the levels 20 
of mRNAs related to ribosome biogenesis could be the cause of the accumulation of the pre-rRNA processing 21 
intermediates. Although our results support a role for Pat1 in transcription, they nevertheless suggest that the 22 
primary cause of the dysregulated mRNA levels is most likely due to Pat1’s role in mRNA decapping and mRNA 23 
degradation. 24 
 25 
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INTRODUCTION 1 
 Modulation of transcription and mRNA degradation is a crucial aspect of eukaryotic gene expression1. The 2 
stability of messenger RNA is controlled by two important structures, the m7G cap at the 5’ end and poly(A) tail at 3 
the 3’ end. Shortening of the poly(A) tail is the rate limiting step in the process of mRNA degradation in yeast 2. 4 
After the shortening of the poly(A) tail, mRNA can be degraded either by the 5’ to 3’ or the 3’ to 5’ decay pathways. 5 
Messenger RNA decay from the 3’ to 5’ direction is facilitated by the cytoplasmic exosome complex. Degradation of 6 
mRNA by the 5’ to 3’ decay pathway is the major pathway of mRNA degradation in yeast 2. It begins with the 7 
removal of the 5’ m7G cap by the decapping enzyme followed by the rapid degradation of the mRNA by the 8 
cytoplasmic 5’ to 3’ exonuclease Xrn1 3,4.  9 
 Pat1 is a key protein that has been proposed to act as a scaffold to coordinate the process of mRNA 10 
degradation in yeast. Pat1 is an evolutionarily conserved mRNA decapping activator found from yeast to mammals 11 
5,6. It has been suggested that Pat1 first represses translation, then recruits and activates the decapping enzyme 5,7-12 
9. Pat1 is a part of Pat1/Lsm1-7 complex, which regulates mRNA decay in the cytoplasm 10,11.  13 
 While the cytoplasmic role of Pat1 as an mRNA decay factor is well studied, recently it has been shown that 14 
Pat1 can enter the nucleus and can shuttle between the nucleus and cytoplasm 12-14. The nuclear role of Pat1 has 15 
been largely overlooked since its initial identification as a Top2-interacting protein, which is the source of its name: 16 
“Protein Associated with Topoisomerase” (Pat1) 15,16. In addition, recent studies have proposed a role for Pat1 in 17 
splicing, transcription and retrograde tRNA import 12,14,17-19. Human Pat1b co-localizes with splicing speckles, 18 
dynamic structures that contain poly(A)+ mRNA, SR proteins and splicing factors, supporting a splicing related 19 
function for Pat1. Its role in transcription was documented by a genome-wide transcriptomics study and in vivo 20 
transcriptional assays 12,17.  Furthermore, Pat1 has also been shown to be a structural component of the yeast 21 
kinetochore. Pat1 has been implicated to be crucial for integrity of the centromeric chromatin and chromosome 22 
segregation 20. 23 
 Another speculation was that Pat1 could bind the nuclear Lsm2-8 complex via the Lsm2 and Lsm3 proteins 21. 24 
Lsm2-8 is the nuclear counterpart to the cytoplasmic Lsm1-7 complex, which functions in splicing, pre-mRNA 25 
decay and ribosome biogenesis (RB) 22-24. Despite these suggestions, its function in the nucleus, beyond 26 
transcription and chromosome segregation, has been mostly speculative. In this work, we addressed these 27 
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possible roles and show that while Pat1 does affect rRNA processing and transcription, the overwhelming 1 
importance of Pat1 is in regulating mRNA stability. 2 
 3 
RESULTS 4 
Pat1 is not required for pre-mRNA splicing.  5 
 To elucidate if Pat1 functions in pre-mRNA splicing, we first examined whether the growth behavior of the pat1∆ 6 
strain is comparable to the known non-essential splicing deficient mutants of the nuclear Lsm2-8 complex (i.e. 7 
lsm6∆ and lsm7∆ mutants). The deletion of lsm1, a component of the cytoplasmic Lsm1-7 complex that does not 8 
affect splicing was used as a negative control 25,26. However, Pat1 is found in the nucleus in this mutant (Figure 9 
S1)13. At 30°C all the deletion strains grew analogously to the WT strain, but at 37°C all the mutants grew slightly 10 
slower. At 20°C, the splicing defective mutants lsm6∆ and lsm7∆ grew at least twenty fold slower than the WT, 11 
while the pat1∆ and lsm1∆ strains had no growth defect (Figure 1A). 12 
 Thereafter, we examined the accumulation of the intron-containing precursor of the U3 snoRNA by northern 13 
analysis, which is a sensitive measure of splicing in yeast 26,27. In the pat1∆ mutant, like the lsm1∆ strain, the pre-14 
U3 species does not accumulate when compared to WT strain. However, as expected, the levels of the pre-U3 15 
RNA were significantly elevated in lsm6∆ and lsm7∆ (Figure 1B). Since Pat1 is not required for splicing of the pre-16 
U3 snoRNA, Pat1 is also most likely is not required for efficient splicing in the nucleus in general.   17 
Pat1 does not function in snoRNA and nuclear pre-mRNA decay.  18 
 The major function of Pat1 in the cytoplasm is to activate the decapping enzyme complex and to promote 19 
mRNA decay 5,7. Therefore, we hypothesized that Pat1 could potentially have similar functions in the nucleus, 20 
where pre-mRNAs undergo co-transcriptional splicing and several other post-transcriptional modifications before 21 
being exported to the cytoplasm as mature mRNAs. Pre-mRNAs whose introns are not spliced out undergo 22 
degradation in the nucleus. Inhibition of the nuclear decay machinery leads to a slight accumulation of mature 23 
mRNAs indicating that pre-mRNA splicing is in constant competition with their decay suggesting that significant 24 
amount of unspliced pre-mRNAs undergo degradation even in wild-type yeast 28.    25 
 To determine the role of Pat1 in nuclear pre-mRNA decay, we used an assay examining pre-mRNAs that 26 
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contain a small nucleolar RNA (snoRNA) in their intronic region. snoRNAs are often located within the intronic 1 
region of pre-mRNAs of genes encoding proteins related to ribosome synthesis or function, although less so in 2 
yeast than in vertebrates. They are processed out when the pre-mRNA undergoes either splicing or degradation 3 
29,30. The presence of snoRNA serves as a steric block to exonucleases. In the deletion mutants that are defective 4 
in nuclear decapping, only 3’ to 5’ exosome mediated decay occurs. This blockage leads to an accumulation of 5’ 5 
degradation intermediates 23,28. Since the Lsm2-8 complex has been shown to facilitate nuclear pre-mRNA 6 
decapping and degradation, strains lacking Lsm6 and Lsm7 were used as positive controls 23.  7 
 To examine if Pat1 affects nuclear pre-mRNA decay, we monitored the accumulation of 5’ unprocessed decay 8 
fragments of the TEF4 pre-mRNA that contains a snoRNA, snR38, in its intronic region, in the pat1∆ mutant by 9 
northern analysis. First, we found the pat1∆ and lsm1∆ strains did not accumulate 5’ unprocessed products of 10 
TEF4 pre-mRNA as compared to the WT strain (Figure 2B) 23. Second, as expected, the lsm6∆ and lsm7∆ mutants 11 
accumulated 5’-unprocessed fragments.  12 
 To confirm these results, we analyzed the pre-mRNA of EFB1 that contains a snoRNA, snR18 in its intronic 13 
region and observed similar results (Figure 2C). Despite the accumulation of the decay products in the lsm6∆ and 14 
lsm7∆ mutants, the levels of mature mRNAs of TEF4 and EFB1 did not change significantly from the WT strain, 15 
similar to the intron containing ACT1 and intron-less PGK1 mRNA (Figure 2C, 2D, and 2E) 23. In contrast, the 16 
abundance of the snoRNAs, snR38, and snR18, increased slightly but significantly in pat1∆ mutant (Figure 2B, 2C, 17 
and 2G). Both intronic and independently transcribed snoRNAs were elevated in the pat1∆ mutant and the lsm 18 
mutants tested here (Figure S2). The cause for the increase in the levels of snoRNAs is unclear.  19 
 A possible explanation could be that the absence of Pat1 may be required for destruction of mature U3 snoRNA 20 
similar to that of strains defective in the nuclear Lsm2-8 complex 31.  As expected, in the strains lacking Lsm6 or 21 
Lsm7, a stable degradation product of U3 snoRNA accumulated. However, the pat1∆ and lsm1∆ strains did not 22 
have significant accumulations, indicating that they are not involved in degradation of the mature U3 snoRNA 23 
(Figure 1B). However, these results illustrate that Pat1 does not facilitate nuclear pre-mRNA decay similar to Lsm1 24 
and unlike Lsm6 and Lsm7. 25 
Absence of Pat1 leads to accumulation of rRNA processing intermediates.  26 
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 Next, we speculated that Pat1 might be required for efficient ribosome biogenesis (RB). Two main observations 1 
support this hypothesis. First, Pat1 was shown to associate with ribosomes 32,33. Second, the Lsm2-8 complex to 2 
which Pat1 has been proposed to bind in the nucleus, is required for rRNA processing 21,24,34. Strains deprived of 3 
proteins required for RB tend to accumulate pre-rRNA processing intermediates, produced due to inefficient or 4 
defective rRNA processing 35. We hypothesized that if Pat1 is required for RB; the pat1∆ mutant should accumulate 5 
such intermediates (Figure 3). The positions of the probes used in this study are diagrammed in the Figure 3A.  6 
 The 35S pre-rRNA transcript accumulated most prominently in the pat1∆ strain to nearly three-fold above that of 7 
the WT strain (Table 1, Figure 3B and 3C). This effect could be rescued with a centromeric plasmid containing a 8 
full-length copy of PAT1 (data not shown). Consistent with the previous studies, in the lsm1∆, lsm6∆ and lsm7∆ 9 
mutants, there was also significant accumulation of 35S pre-rRNA precursor 24,36. 10 
 The 35S primary transcript undergoes initial processing by cleavages at the A0 and A1 sites to form a 32S pre-11 
rRNA precursor, which then rapidly undergoes cleavage at A2. The A2 cleavage separates the pre-rRNA transcript 12 
into precursors of the mature 25S and 18S rRNAs. 20S pre-rRNA, the precursor of the 18S rRNA significantly 13 
accumulated in the pat1∆ mutant, which was also could be rescued with a centromeric plasmid containing genomic 14 
copy of PAT1 (Figure 3B, 3C, and data not shown). The 20S pre-rRNA precursor clearly accumulated in lsm1∆, 15 
lsm6∆ and lsm7∆ mutants as well at 30°C. 16 
 The amount of the 27SA pre-rRNA species, the 25S rRNA precursor products that form after A2 and A3 17 
cleavages, did not change significantly in the pat1∆ and lsm1∆ mutants. In contrast, their levels significantly 18 
decreased in lsm6∆ and lsm7∆ mutants. We also observed a significant increase in the levels of 27S pre-rRNA 19 
species in pat1∆ but not the other strains (Figure 3B and 3C). Finally, the amount of mature 18S and 25S rRNA did 20 
not change significantly in the pat1∆ strain (Figure 3B and 3C).  21 
 Taken together, these results suggest that Pat1 is required for pre-rRNA processing of 35S rRNA, 27S pre-22 
rRNA and 20S pre-rRNA. Therefore, Pat1 and Lsm1 might act together or in similar pathways to affect rRNA 23 
processing differently from Lsm2-8 complex. 24 
Ribosomal RNA processing is delayed in the pat1∆ mutant.  25 
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 The accumulated intermediates in the pat1∆ mutant could be from a delay in rRNA processing. To examine this 1 
question directly, we performed pulse-chase analyses of pre-rRNA processing in the WT and pat1∆ strains. One of 2 
the first pre-rRNA products generated is the 35S pre-rRNA transcript. However, it is rapidly processed into 27S pre-3 
rRNA and 20S pre-rRNA species 37.  It is noteworthy that we observed a much longer persistence of the 35S pre-4 
rRNA in the pat1∆ mutant consistent with the accumulation of intermediates observed at steady-state (Compare 5 
Figure 3B and 3D), while the WT strain underwent rapid processing into the subsequent products.   6 
 There was also a delay in the processing of the 27SA pre-rRNA species in the pat1∆ mutant compared to the 7 
WT strain. The final maturation of the 20S pre-rRNA to 18S occurs in the cytoplasm. Therefore, the delay in 8 
processing of this pre-rRNA precursor suggests that Pat1 may either affect the export of the ribosome or the 9 
cytoplasmic processing of 18S rRNA (Figure 3D) 38,39.  10 
Pat1 mutant has synthetic growth defects with the ribosomal RNA surveillance machinery.  11 
 The pat1∆ mutant accumulates abnormal levels of rRNA processing intermediates. However, additional 12 
aberrant intermediates could be eliminated rapidly by the nuclear surveillance machinery and thus not observed. 13 
To analyze if any such products are formed in the pat1∆ strain, we deleted TRF4, the poly(A) polymerase of the 14 
TRAMP (Trf4/Air2/Mtr4 Polyadenylation). The TRAMP complex facilitates the addition of four to six adenosines at 15 
the 3’ end of an abnormal rRNA intermediates.  We also deleted RRP6, the nuclear-specific component of the 16 
exosome complex that degrades these aberrant rRNAs in the pat1∆ and WT strain backgrounds 40-42. 17 
 To determine if a genetic relationship exists between Pat1 and the nuclear surveillance machinery, we 18 
examined the growth of the single (pat1∆, trf4∆, and rrp6∆) and the double deletion strains (pat1∆ trf4∆ and pat1∆ 19 
rrp6∆). As in Figure 1A, the pat1∆ mutant grew slightly slower than WT at 37°C. The growth of the rrp6∆ mutant 20 
was severely inhibited at 37°C, but grew comparably to the WT strain at 20°C and 30°C as reported previously 21 
(Figure 3E) (46).  When combined with the pat1∆ mutation, the 37°C growth inhibition of the rrp6∆ mutant became 22 
more pronounced.  23 
 The single deletion mutant trf4∆ was cold sensitive at 20°C, but grew like WT strain at all the other temperatures 24 
examined (Figure 3E). The pat1∆ trf4∆ double deletion mutant was synthetically slow growing at all temperatures, 25 
exhibiting the strongest growth defect at 20°C. Growth inhibition of the pat1∆ rrp6∆ mutant at 37°C and pat1∆ trf4∆ 26 
strain at 20°C is due to slower growth as viability was unaffected (data not shown). Altogether, these results show 27 
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that Pat1 has a synthetic sick relationship with the nuclear exosome and TRAMP complex mutants. One possible 1 
source of these synthetic relationships could be presence of abnormal levels of rRNA intermediates generated in 2 
the pat1∆ strain.  We therefore examined the levels of rRNA processing intermediates in the single and double 3 
mutants. 4 
 Although there are subtle rRNA processing defects in the double deletion mutants (pat1∆ rrp6∆ and pat1∆ trf4∆) 5 
compared to the single mutants, we did not observe significant synergistic increases of rRNA intermediates in 6 
either the trf4∆ pat1∆ or the rrp6∆ pat1∆ mutant (Figure S4).  For instance, the levels of 27SA, 27S, 18S and 25S 7 
rRNA increased in the trf4∆ pat1∆ mutant at both 30°C and 37°C but not at 20°C. In rrp6∆ pat1∆ mutant, 27SA and 8 
27S pre-rRNA intermediates accumulated at 30°C and their levels decreased at 37°C. The levels of 20S pre-rRNA 9 
stabilized at 20°C and 30°C but not at 37°C in the double mutants compared to the single mutants (rrp6∆ and 10 
trf4∆). Stabilization of the 23S pre-rRNA was also observed in trf4∆ pat1∆ at all the temperatures. Interestingly, 11 
while the mature 25S to 18S rRNA ratio was altered in the trf4∆ pat1∆ strain at 30°C, there was only a modest 12 
growth defect. This suggests that the synthetic sickness observed in these mutants might not be linked to RB 13 
(Figure 3E and S4). We envisage that the synthetic sick growth of trf4∆ pat1∆ is due to either undetected 14 
intermediates, which are not eliminated by the TRAMP complex or alternatively a TRAMP independent role of Trf4.  15 
 The nuclear exosome also promotes the degradation of abnormal rRNA processing intermediates. As shown 16 
previously, we also observed the accumulation of decay products in both the rrp6∆ and pat1∆ rrp6∆ mutants 17 
(Figure 5, rrp6∆ and pat1∆ rrp6∆ lanes with products indicated with *) 40. In the trf4∆ single mutant, similar decay 18 
intermediates were observed at 20°C (Figure 5 with products indicated with ‘). We do not know the source of these 19 
decay products. Interestingly, in the pat1∆ trf4∆ double mutant, we observed an increase of these species 20 
indicating a possible role of Pat1 in Trf4 dependent decay of the pre-rRNA processing intermediates. 21 
 We also considered the possibility that the abnormal rRNA precursors containing pre-ribosomes generated in 22 
the pat1∆ mutant might be exported to the cytoplasm where they could be detected by the nonfunctional rRNA 23 
decay pathway that recognizes ribosomes with aberrant rRNA 43. This pathway relies on the Dom34 and Hbs1 24 
proteins to recognize faulty 40S ribosomes and target them for destruction by Xrn1 and the cytoplasmic exosome. 25 
To determine whether a genetic relationship exists between PAT1 and DOM34 or HBS1, we monitored the growth 26 
of the individual deletion mutants, and those combined with the pat1∆ mutation at various temperatures. The 27 
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growth assays demonstrated no synthetic genetic relationship between Pat1 and nonfunctional rRNA decay 1 
pathway proteins Dom34 and Hbs1 (Figure S3).   2 
Pat1 mutants that are defective in decapping also exhibit rRNA processing defects.  3 
 Next, we tested if the mRNA decapping function of Pat1 and RB are linked. Pat1 affects multiple processes of 4 
gene expression. Pat1 for example, not only strongly affects mRNA decapping but can also alter translation and 5 
transcription 5,7,12. Previous works have examined the role of different truncation mutants of Pat1 in mRNA 6 
decapping, translation repression and protein-protein interaction 5,9.  7 
 The Middle or M-domain of Pat1, consisting of amino acids 254-422, was shown to be required but not sufficient 8 
for decapping 9. When expressed alone, the M-domain behaved like a pat1 null mutant in decapping ability 9 
(unpublished data). The N-terminal or N-domain (1-254) and C-terminal or C-domain (422-796) were proposed to 10 
enhance the ability of M-domain to promote decapping. However, the M and C-domains together were 11 
demonstrated to be the most important for translational repression in vitro 5,9.   12 
 First, we tested the growth behavior of Pat1 truncation mutants. We wished to examined them in the 13 
background used in our study (BY4741) to confirm that they perform the same as in the different strain background 14 
previously used 9,44. As shown in Pilkington et al. 9, at 36°C, the pat1∆ mutant demonstrates growth inhibition 15 
(Figure 4A) 9. Consistent with the previous results, all the mutants lacking the M-domain showed growth defects, 16 
although to differing extents. While our data qualitatively agrees with Pilkington et al., some strain specific 17 
differences may account for the pat1∆ strain and the mutants lacking the M-domain being unable to grow at 35°C 18 
and the growth inhibition in other mutants being much more pronounced than in BY4741 than in the strain used by 19 
Pilkington et al. 9. 20 
 Since the pat1∆ mutant in our strain background exhibited growth differences compared to the one previously 21 
examined, we wished to confirm the mutants linkage to mRNA decapping in BY4741 strain. mRNA decapping in 22 
vivo can be assessed using a reporter mRNA containing a poly(G) tract in its 3’ UTR, which serves as a steric 23 
block to 5’ to 3’ degradation and results in the generation of an mRNA decay intermediate or decay fragment 24 
(Figure S5). As the generation of the fragment is analogous to the efficiency of decapping, the levels of this 25 
fragment compared to the full-length mRNA represents an accurate measure of the ability of mRNA decapping 9. 26 
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Using MFA2 mRNA, we found that the M-domain is required for decapping, and that the N and M contribute to 1 
differing extents (Figure 4C), similar to published results 9.  2 
 Since we have determined the role of the truncations in decapping, we then investigated how different domains 3 
of Pat1 affect pre-rRNA processing. We observed four main results from these analyses (Figure 4B). First, 35S 4 
pre-rRNA, 27S pre-rRNA and 20S pre-rRNA clearly accumulated in the pat1∆ strain with no significant decrease in 5 
the mature 25S and 18S rRNAs (Figure 4B, pat1∆). Second, the truncation mutants lacking the M-domain 6 
accumulated 35S pre-rRNA (Figure 4B, Pat1-N and Pat1-C). Third, deletion of both the M and C-domain together 7 
showed similar defects as deletion of the entire PAT1 gene (Figure 4B, Pat1-N). Finally, the pat1∆ mutant with 8 
N+M or M+C together did not fully rescue the rRNA processing defects, suggesting that the N-domain and the C-9 
domain are also needed for efficient rRNA processing. In conclusion, these results show that the mutants of Pat1 10 
that are deficient in mRNA decapping are also defective in rRNA processing, indicating that these two processes 11 
are linked. 12 
Pat1 is linked to a transcription.  13 
 One possibility for the delay in ribosomal processing when Pat1 is absent could be due to RNA polymerase 14 
transcription. Pat1 has been shown to facilitate transcription elongation in yeast 12. To evaluate how the different 15 
truncation mutants of Pat1 affect transcription elongation, we expressed the Pat1 mutants in pat1∆ strain and 16 
examined their growth on media containing 6-azauracil (6-AU). 6-AU is a transcriptional elongation inhibitor that 17 
depletes the intracellular GTP pools. Mutants that are deficient in Pol I or Pol II transcriptional elongation are 18 
hypersensitive to 6-AU 45,46.  19 
 The Pat1 domains required for efficient decapping ability are also required for transcriptional elongation as 20 
assessed by 6-AU sensitivity. Loss of Pat1 leads to complete inhibition of growth in 50µg/ml 6-AU. The Pat1 21 
mutants’ growth inhibition was correlated with the amount of decapping defect observed, with the M-domain being 22 
most important (Compare Figure 4B and 4D). Similarly, it was previously found that Pat1 lacking the M-domain was 23 
also defective in chromosome segregation 20. These results indicate that, as suggested by previous studies, 24 
regulation of mRNA decay by Pat1 is linked to its role in transcriptional elongation.  25 
 26 
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Lack of Pat1 leads to increase in mRNA abundance.  1 
 To further examine if transcription could be the source of the rRNA processing defects, we analyzed 2 
transcriptomics data from Sun et al 17. This study calculated the total abundance, transcription rate and decay rate 3 
of around 4000 mRNAs in 46 deletion mutants that affect mRNA decay, including pat1∆. We analyzed the mRNAs 4 
that had been significantly reduced in abundance in the pat1∆ mutant, and found a significant enrichment in GO 5 
categories involved in RB (Figure S6). This decrease in abundance is due to reduced transcription in the pat1∆ 6 
mutant in the study. These results suggest that the rRNA processing defects in pat1∆ could be attributable to 7 
decrease in the levels of these mRNAs and that the M-domain of Pat1 is important for a transcription of these 8 
genes. 9 
 To validate our hypothesis, we selected eight RB-related mRNAs that were especially decreased in the Sun et 10 
al. dataset in the pat1∆ mutant and analyzed them by northern analyses. Surprisingly, the levels of these mRNAs 11 
increased significantly in the pat1∆ mutant as compared to WT strain (Figure 7). We then selected an additional set 12 
of mRNAs that are non-RB-related. Again, we saw a significant increase in mRNA abundance of these genes. We 13 
next examined three mRNAs increased in abundance in the Sun et al. dataset. These mRNA increased as well, 14 
although more modestly than reported except for the HSP26 mRNA. Finally, we wished to examine whether the 15 
mRNA encoding for ribosomal protein are also increased in the pat1∆ mutant. We selected three genes, and found 16 
only a slight increase of their levels. When normalized to ACT1 mRNA instead of SCR1 RNA, no significant 17 
difference in their levels between the pat1∆ and WT strains was observed (Figure S7). We could not compare the 18 
mRNA encoding for ribosomal protein levels to the published transcriptomics dataset, as they were largely absent 19 
in the study.  20 
 To eliminate the possibility of strain specific differences being the cause of the discrepancy, some of the above 21 
tested mRNAs were analyzed in the same pat1∆ strain used to obtain the Sun et al. dataset. We observed a similar 22 
increase in the levels of RB genes related mRNAs and no change in the levels of ribosomal protein gene mRNAs 23 
consistent with the results with our strain (data not shown). To test if this increase in the levels of mRNA is due to 24 
lack of efficient mRNA decapping, we analyzed the amounts of full-length mRNAs in the decapping assay in Figure 25 
S5. The strain lacking Pat1 accumulated at least 4 fold more full-length mRNA compared to the strain having a 26 
genomic copy of PAT1 (Figure S5A and S5B). 27 
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 These results suggest that the mRNA levels are dysregulated in the pat1∆ mutant, presumably due to the 1 
effects of mRNA decapping and mRNA decay. We found that ribosomal biogenesis mRNAs trend towards 2 
significant increases in abundance, while the ribosomal protein mRNAs are not increased. This discordance at the 3 
mRNA level may be the source of the biogenesis defect.  4 
 To further confirm our hypothesis that the increase in mRNA levels is due to the lack of efficient decapping in 5 
the pat1∆ mutant, we examined and compared other mutants in 5’-to-3’ decay pathway to that of the pat1∆ deletion 6 
strain by northern analysis.  Similar to the pat1∆ deletion mutant, the levels of the RB mRNAs were raised in xrn1∆ 7 
and lsm1∆ mutants (Figure S8).  Taken together, these results are consistent with Pat1 affecting the levels of RB 8 
mRNAs through decapping.   9 
 10 
DISCUSSION 11 
 Since its discovery as a topoisomerase II interacting protein, Pat1 has been implicated to have a role in the 12 
nucleus (Figure S1) 15,16 . Although, subsequent studies have primarily concentrated on its cytoplasmic role as a 13 
translational repressor and mRNA decapping activator, several recent studies have provided evidence and 14 
proposed that Pat1 could have a function in the nucleus 5-7,12,14.  One line of evidence for Pat1 entering the nucleus 15 
is that Pat1 accumulates there when the Lsm1 protein is absent 13. The nuclear accumulation in the lsm1∆ mutant 16 
could be due to loss of cytoplasmic anchoring, perhaps via P bodies 13. 17 
 In this work, we investigated these roles and show that the absence of Pat1 does not affect splicing or nuclear 18 
pre-mRNA degradation. Interestingly, it affects rRNA processing resulting in abnormal intermediates, generated 19 
from multiple steps, especially the 35S, 27S and 20S pre-rRNAs (Figure 3).   20 
 The ribosome biogenesis defects of the pat1∆ and other mutants we examined are largely consistent with the 21 
previously published data on the lsm1∆, lsm6∆ and lsm7∆ mutants 24.  Namely, that defects in processing of the 22 
35S rRNA was delayed, which is a commonly observed defect in ribosome biogenesis mutants 36.  We found an 23 
increase in the 20S pre-rRNA levels at 30°C for the pat1∆ mutant and lsm1∆ mutant. As lsm1∆ mutant was shown 24 
to have decreased levels of 20S at 37°C, we observed that the amount of the 20S pre-rRNA decreased pat1∆ 37°C 25 
(Figure S4) 24. Similarly, the lsm6 and lsm7 mutants have 20S accumulation at 20°C by northern blot analyses in 26 
another study 36. Taken together, the lsm1∆ has broadly similar defects in rRNA processing to the pat1∆ mutant. 27 
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 These results suggest that Pat1 does not affect a single step in RB, but rather affects the process of rRNA 1 
processing globally. Nevertheless, absence of Pat1 could allow generation of products that are recognized by the 2 
ribosome quality control machinery and not be revealed through our steady-state and pulse-chase analyses as has 3 
been previously described 47.   4 
 In this study, we showed that Pat1 has a synthetic sick relationship with Rrp6 and Trf4. Despite these synthetic 5 
relationships, we did not uncover any clear defects that could account for the synthetic sickness. Pat1 and Lsm1 6 
affect rRNA processing similarly. Pat1 has been shown to shuttle between the nucleus and the cytoplasm, and can 7 
recognize oligoadenylated (oligo(A)) RNAs.  Therefore, it is possible that Pat1 together with Lsm1 facilitates the 8 
recognition of the short oligo(A) tails that are added by the TRAMP complex in the nucleus. This interaction may 9 
facilitate the processing of the TRAMP dependent oligoadenylated RNAs such as non-coding RNA, snoRNAs etc. 10 
or other alternate functions of the TRAMP complex 12,14,48. Strengthening our hypothesis, we also observed an 11 
increase in the levels of snoRNAs in pat1∆ mutant (Figure 2, Figure S2).  12 
 Other roles proposed for the TRAMP complex and the exosome include termination of snoRNA transcription, 13 
determination of mRNA poly(A) length and control of pervasive transcription of noncoding RNA in general as well 14 
as rDNA copy number in particular 49-52.  The most likely linkage of Pat1 to the TRAMP complex may be in control 15 
of rDNA copy number.   Evidence supporting this is that the pat1∆ mutant mimics the rDNA recombination 16 
phenotype of top1∆ and top2∆ mutants.  Furthermore, this is consistent with several studies reporting that top1∆ is 17 
either synthetically sick or lethal with trf4∆ 52-55. 18 
 The possibility exists that the Pat1/Lsm1-7 complex could directly interact with rRNA processing intermediates, 19 
suggested by its ribosomal association and precipitation of 20S pre-rRNA with Lsm124. However, based on the 20 
observations that Pat1 affects multiple steps in rRNA processing, we theorized that lack of Pat1 might lead to 21 
down-regulation of transcription of RB genes as a class. Such a model was suggested by our analysis of a recent 22 
study that had examined the effect of a pat1 deletion on mRNA abundance, decay and transcription 17. In their 23 
data, we found that the transcription of mRNAs related to RB was down regulated leading to a decrease in the total 24 
abundance of these mRNAs in pat1∆ mutant (Figure S6). 25 
 Surprisingly, when we validated these results by northern analyses, the total abundance of most RB mRNAs 26 
that we examined was instead increased in the pat1∆ mutant. This increase was seen both with normalization 27 
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against the non-coding RNA component of the signal recognition particle, scR1 and with ACT1 mRNA (Figure 5 1 
and S7). However, the study observed that the absence of Pat1 reduced transcription genome-wide 17.  Similarly, 2 
GAL1 transcription assays in another study suggested that Pat1 promotes transcription elongation 12.  Taking 3 
together, these data suggest that in the absence of Pat1, there should be reduced transcription, while we find the 4 
opposite result for the ribosomal biogenesis genes.  Although previous studies and our results demonstrated that 5 
Pat1’s role in transcriptional elongation is linked to its role in mRNA degradation, the increase in total mRNA 6 
abundance of RB mRNAs tested here suggest that the dysregulation of mRNA levels in the pat1∆ mutant is due to 7 
poor mRNA decapping and as result reduced decay. Increase in RB mRNA levels in other decapping pathway 8 
mutants, xrn1∆ and lsm1∆, strongly support our assumption that the ribosome biogenesis defects observed in 9 
pat1∆ strain are due to defects in mRNA decay (Figure S8).   However, it should be noted that both Xrn1 and Lsm1 10 
have been previously been reported as ribosome biogenesis factors with defects in rRNA proccesing 35,56,57.  11 
Specifically, the deletion of xrn1 affects processing at the A0, A1, A2 and A3 sites as well as the 5’ end processing of 12 
the 27SA3 and 5.8S rRNAs. For its part, the absence of Lsm1 delays A0 and A1 cleavages and affects 20S rRNA 13 
levels. 14 
 Interestingly, while we found most RB genes were up regulated in the pat1∆ mutant, the ribosomal protein 15 
encoding mRNAs were not elevated in the pat1∆ mutant when normalized to ACT1 mRNA (Figure S7). These data 16 
suggest a possibility that Pat1 specifically targets the RB genes for degradation and thus these genes are elevated 17 
in its absence. Similarly, mRNA encoding ribosomal biogenesis factors and ribosomal proteins have been shown 18 
previously to have different decay profiles 58. It is tempting to speculate that Pat1 could control this differential 19 
decay, which was observed most significantly upon glucose deprivation, where Pat1 plays a role in translational 20 
repression 7.  Such a regulation of the decay of a class of mRNA was first suggested from a genome-wide study of 21 
mRNA decay 59. By specifically looking at mRNA degradation genome-wide, ribosome biogenesis factors were 22 
suggested to be regulated at the level of mRNA stability 60, which is supported by our results. Further analysis of 23 
the dataset 17 combined with analysis of UTR lengths revealed a motif specific for rapid degradation of RB factors 24 
61.  This sequence is similar to that recognized by the Pat1/Lsm1-7 complex, suggesting a possibility that Pat1 25 
might play a role in the differential decay of RB and ribosomal proteins mRNA 62.  26 
 The increase in the levels of mRNA for RB factors may alter the composition of the RB machinery to assemble 27 
and process ribosomes. These results suggest a model in which ribosomal biogenesis is a sensitive sensor for 28 
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correct stoichiometry between ribosomal components, since this process has more than 200 trans-acting factors 63. 1 
Consistent with this proposition, in a genome-wide study, overexpression of four of the top five most up-regulated 2 
mRNAs involved in ribosome biogenesis that we examined were either lethal or sick 64.  While many studies have 3 
examined the use of conditional promoters to deplete ribosomal biogenesis factors’ mRNAs, few have examined 4 
the effect of over-expression.  However, overexpression of RB transcription factors such as Sfp1 causes toxicity 5 
concomitant with the induction of RB mRNA 65. 6 
 In conclusion, our results suggest that Pat1’s role in the cell is predominantly in mRNA degradation rather than 7 
in transcription. Pat1 appears to affect the levels of mRNA encoding ribosomal proteins and those encoding RB 8 
biogenesis factors.  These data support a model in which Pat1 regulates mRNA mRNA stability differentially 9 
amongst different classes of mRNAs in a coordinated fashion to modulate gene expression. 10 
 11 
MATERIALS AND METHODS 12 
Yeast strains, plasmids, and cell culture. 13 
 The strains and plasmids used in this work are listed in Supplementary Tables S1 and S2 respectively. Double 14 
deletion mutants were constructed by crossing two respective isogenic single mutants of opposing mating type. 15 
Strains used in this study were cultured using rich YEPD or synthetic complete medium lacking the appropriate 16 
amino acids. Unless otherwise mentioned cells were inoculated from overnight cultures to 0.05-0.08 OD in fresh 17 
medium, grown at 30°C and harvested at ~0.5 O.D. For decapping assay, cells were grown in SC -Ura –Leu with 18 
2% sucrose overnight. Cells were washed twice and inoculated to 0.05 O.D in SC -Ura –Leu with 2% galactose to 19 
induce the expression of pGAL-MFA2pG and were harvested at ~ 0.3 O.D 66. 20 
 21 
Live cell imaging. 22 
 Cells were grown in SDC-His liquid medium to exponential phase at 30°C. Fluorescence images were captured 23 
using Nikon eclipse 90i microscope with Hamamatsu ORCA-ER digital camera. Pictures were then processed 24 
using ImageJ and Adobe Illustrator CS6 67. 25 
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 1 
Yeast Growth Assay.  2 
 Strains were grown overnight at 30°C in the appropriate medium. 10ml of overnight grown cultures were 3 
harvested and re-suspended to1.0 O.D. Cells were 10-fold serially diluted and ~ 3µl of each dilution was spotted 4 
with a pin tool (V&P Scientific) onto appropriate plates. Plates were incubated at the indicated temperatures for 2 5 
days (30°C or 37°C) or 4 days (20°C).  6 
 7 
Northern Analysis.  8 
 Total RNA extractions were performed as described in 68 with small modifications. Unless mentioned otherwise, 9 
10 µg of total RNA was analyzed by either 1.2% formaldehyde agarose gel or 6% polyacrylamide/7.5 M urea gel. 10 
RNA was either capillary transferred or electro blotted onto a nylon membrane 69. Northern analysis was performed 11 
with oligonucleotide probes or random labeled probes. The oligonucleotides and primers used for the preparation 12 
of probes in this work are listed in Supplementary Table 3.  13 
 14 
Pulse–Chase Analysis.  15 
 The pulse-chase analysis was done as described 37 with modifications. WT and pat1∆ strains were grown to 16 
0.4-0.5 O.D at 30°C, harvested, and re-suspended to 1.0 O.D in SDC-Ura liquid medium. Cells were further grown 17 
for 30 minutes before they were pulse-labeled for 1 min with 3H uracil and then chased with excess of 18 
nonradioactive uracil. At the indicated times, 800µl sample was transferred to 2ml Eppendorf half filled with crushed 19 
ice placed in ice. Samples were spun down quickly and frozen in dry ice 70. Total RNA was isolated by the hot 20 
phenol method as described in 71. 20,000 cpm/sample of RNA was separated on a 1.2% formaldehyde agarose gel 21 
and transferred to a Hybond-N membrane (GE) by capillary transfer overnight. The membrane was UV-cross-22 
linked, sprayed with En3HanceTM (PerkinElmer) according to the manufacturer’s instructions and exposed to a film 23 
for 5 days at −80°C. 24 
 25 
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TABLES AND FIGURES LEGENDS   12 
 13 
Table 1. Relative amounts of rRNA processing intermediates in pat1 and lsm mutants.  14 
 35S 27SA 27S 20S 25S 18S 
WT 1.00   1.00 1.00 1.00 1.00 1.00
pat1∆ 2.73 ± 0.30 1.16 ± 0.18 1.28 ± 0.10 1.55 ± 0.17 1.03 ± 0.20 1.00 ± 0.06
lsm1∆ 2.39 ± 0.057 0.92 ± 0.19 1.19 ± 0.15 1.37 ± 0.18 1.01 ± 0.15 0.96 ± 0.04
lsm6∆ 1.83 ± 0.32 0.71 ± 0.10 0.93 ± 0.14 1.35 ± 0.37 0.87 ± 0.10 0.88 ± 0.03
lsm7∆ 2.25 ± 0.44 0.71 ± 0.07 1.13 ± 0.16 1.63 ± 0.26 0.89 ± 0.06 0.91 ± 0.04
 15 
 16 
Figure 1. Deletion of Pat1 does not affect splicing of pre-U3 snoRNA. (A) Strains indicated were grown 17 
overnight at 30°C. Cells were then serially diluted 1:10, spotted on YEPD plates and grown at the indicated 18 
temperatures. (B) Northern analysis of the pre-U3 snoRNA splicing on a 6% denaturing polyacrylamide gel, blotted, 19 
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and hybridized with oligonucleotide probe complementary U3 RNA. The unspliced U3 RNA is indicated as “Pre-U3 1 
Species”. The mature and truncated U3 species are also indicated. scR1 is the loading control.  2 
   3 
Figure 2. Deletion of Pat1 does not accumulate 5’-unprocessed fragments of pre-mRNAs having intronic 4 
snoRNAs. (A) Pictorial representation of an mRNA containing snoRNA in its intronic region, showing the relative 5 
positions of the oligonucleotide probes used in this study. (B) Left: Northern analysis of the TEF4 mRNA indicating 6 
5’ decay product, the snR38 snoRNA and spliced full-length TEF4. To the left of each gel panel is indicated in 7 
brackets the oligonucleotide used for probing. The strains used are indicated above the figure. Total RNA was 8 
analyzed by agarose or PAGE northern analysis as appropriate. Right: The splicing products and decay 9 
intermediates are schematically depicted next to the indicated RNA species on the left. (C) As above for the EFB1 10 
gene. (D) Northern analysis for the ACT1 gene in the strains indicated above probed with randomly primed DNA. 11 
(E) As above for the PGK1 gene. (F) As above for the SCR1 gene and probed with oTN100 (G) Quantification of 12 
the relative percentages of the mature mRNA and snoRNA of EFB1 and TEF4 normalized to scR1. The data 13 
represents averages of at least three independent experiments, Error = SD. Two tailed independent sample t-test 14 
with unequal variance was used. * Indicates p-values of <0.05, ** indicates p-values of <0.01, and *** indicates p-15 
values of <0.001. (H) Quantification of the relative percentages of the PGK1 and ACT1 mRNA normalized to scR1.  16 
 17 
Figure 3. Pat1 is required for rRNA maturation. (A) Schematic representation of pre-35S rRNA and the relative 18 
positions of the oligonucleotide probes used for northern analysis. (B) Northern analysis of rRNA processing. The 19 
oligonucleotide probes used for probing are indicated in the brackets. RNA products analyzed are indicated to the 20 
right. The rRNA species are schematically depicted next to the indicated rRNA products. Strains examined are 21 
indicated at the top of the panels. (C) Quantification of rRNA intermediates shown in panel B normalized to scR1. n 22 
= 3, Error bar = SD and p-values as indicated in Figure 2 (D) Pulse-chase analysis of WT and pat1∆ strains. 23 
Strains were pulse-labeled for 1 min and chased with cold uracil for the indicated times listed above. The pre-24 
rRNAs and rRNAs are indicated on the left and the schematic representation of rRNA species is on the right. (E) 25 
Growth assay for the WT, single, and double deletion strains indicated in the figure. Cells were grown overnight, 26 
serially diluted, spotted on YEPD plates and grown at the given temperatures. 27 
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 1 
Figure 4. Domains of Pat1 that are required for mRNA decapping are also required for rRNA processing. (A) 2 
Growth of different truncation mutants of Pat1. Constructs containing different domains of Pat1 were transformed 3 
into pat1∆ mutant. Strains were grown in SDC–Ura medium overnight at 30°C. Cells were serially diluted 1:10, 4 
spotted on SDC–Ura plates and grown at the temperatures indicated. (B) In vivo mRNA decapping efficiency of 5 
Pat1 truncation mutants grown. Northern blots were probed for the MFA2pG gene with oTN121. The relative 6 
percentage of pG decay fragment to full-length MFA2pG is indicated. n = 3, Error bars and p-values as in Figure 2 7 
(C) rRNA processing in the Pat1 truncation mutants. Northern analysis performed as panel B. n = 3. The 8 
oligonucleotide probes used for probing are indicated in the brackets to the left. rRNA processing intermediates are 9 
indicated to the right. The relative amounts of the rRNA intermediates is given at the bottom of the each panel, 10 
corresponding to the order of the species on the rRNA northern, with the species in parenthesis given next to it. 11 
The schematic representation of the rRNA processing intermediates is depicted to the right of the indicated rRNA 12 
species. (D) Pat1 mutants are sensitive to 6-AU. Growth of the pat1 mutants was analyzed as in panel A. Cells 13 
were spotted on SDC–Ura plates or SDC–Ura+ 6-AU (50ug/ml) plates. 14 
 15 
Figure 5. RB-related mRNAs are up regulated in pat1 deletion mutant.  Quantification of the northern analysis 16 
of the mRNAs belonging to different classes of differentially expressed mRNAs in pat1∆ mutant from Sun et al. 17 17 
normalized to SCR1 RNA. Total RNA from WT and pat1∆ strains grown at 30°C to 0.5 O.D was extracted and 18 
separated on a 1.2 % agarose gel. mRNAs indicated in the X-axis were probed with randomly primed probes made 19 
with primers listed in Table S3. Y-axis is plotted in log2 scale. Different categories of mRNAs from Sun et al. 17 20 
examined in this study are indicated at the bottom of the graph. n = 3, Error bar = SD and p-values as given in 21 
Figure 2.  22 
 23 
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